Feline hypersomatotropism associated with insulin-refractory diabetes mellitus and favorable response to cabergoline therapy: a case report
DOI:
https://doi.org/10.34188/bjaerv9n3-216Palavras-chave:
acromegaly, feline, diabetes mellitus, cabergoline, dapagliflozinResumo
Hypersomatotropism (HST) is characterized by increased serum concentrations of growth hormone (GH) and insulin-like growth factor-1 (IGF-1), potentially resulting in acromegalic features, insulin resistance, diabetes mellitus (DM), nephropathy, organomegaly, cardiomyopathy, and other systemic abnormalities. This report describes the case of an elderly female cat with diabetes mellitus refractory to high-dose insulin therapy combined with an SGLT2 inhibitor. The patient presented primarily with nephropathy, adrenal and hepatic enlargement, pancreatitis, transient restrictive cardiomyopathy, enlarged paws, craniofacial bone enlargement, and prognathism. Based on the suspicion of HST, serum IGF-1 concentration was measured and contrast-enhanced computed tomography (CT) of the brain was performed, revealing an IGF-1 concentration >1,000 ng/mL and a pituitary mass within the sella turcica, respectively. These findings confirmed the diagnosis of hypersomatotropism secondary to a GH-secreting pituitary tumor. In addition to DM management, treatment was initiated with cabergoline at 10 μg/kg orally once daily (SID). The patient showed favorable clinical and laboratory responses, including improvement of acromegalic features and increased responsiveness to insulin therapy. (Scudder; Church, 2024).
Referências
Berg, R.I., Nelson, R.W., Feldman, E.C., Kass, P.H., Pollard, R., & Refsal, K.R. (2007). Serum insulin-like growth factor-I concentration in cats with diabetes mellitus and acromegaly. Journal of Veterinary Internal Medicine, 21(5), 892-8. https://doi.org/10.1892/08916640
Corsini, A., Niessen, S.J., Miceli D.D., Caney, S., Zeugswetter, F.K., Sieber-Ruckstuhl, N.S., Arenas, C., Fleeman, L.M., Leal, R.O., Battellino, M., Fracassi,
F. (2022). Quality of life and response to treatment in cats with hypersomatotropism: the owners’ point of view. Journal of Feline Medicine and Surgery, 24(8), 175-182. https://doi.org/10.1177/1098612X221098718
Scudder, C. J., Hazuchova, K., Gostelow, R., Church, D. B., Forcada, Y., Fowkes, R. C., & Niessen, S. J. (2021). Estudo piloto avaliando o uso da cabergolina no tratamento de gatos com hipersomatotropismo e diabetes mellitus. Revista de medicina e cirurgia felina, 23(2), 131–137. https://doi.org/10.1177/1098612X20933213.
Feldman, E.C., & Nelson, R.W. (2015). Disorders of Growth Hormone. Em E.C.
Feldman, R.W. Nelson (Eds), Canine and Feline Endocrinology (pp. 25-60). Elsevier. https://doi.org/10.1016/C2010-0-67113-6
Felix, T.R., & Celestino, T.O., & Pinheiro, A.R.A., & Silva, I.N.G., & Júnior, H.N.A., & Viana, D.A., Xavier, F.A.F., & Araújo, S.L. (2026). Obesidade em felinos e distúrbios urinários: mecanismos metabólicos e paralelos com medicina humana. Brazilian journal of animal and environmental research (bjaer).10.34188/bjaerv9n2-110.
Fleeman, L., & Gostelow, R. (2020). Updates in feline diabetes mellitus and hypersomatotropism. Veterinary Clinics of North America: Small Animal Practice. 50(5): 1085-1105. https://doi.org/10.1016/j.cvsm.2020.06.005
Hurty, C.A., & Flatland, B. F. (2005). Feline acromegaly: a review of the syndrome. Journal of the American Animal Hospital Association, 41(5), 292-7. https://doi.org/10.5326/0410292
Meij, B.P., Kooistra, H.S., Galac, S., Valtolina, C., Bokhorst, K.L.V., Fracassi, F., & Rosenberg, D. (2021). Evaluation of hypophysectomy for treatment of hypersomatotropism in 25 cats. Journal of Veterinary Internal Medicine, 35(2), 834-842. https://doi.org/10.1111/jvim.16047
Miceli, D.D., García, J.D., Pompili, G.A., Pignataro, O.P., Ferraris, S., & Guitelman, M. (2022). Cabergoline treatment in cats with diabetes mellitus and hypersomatotropism. Journal of Feline Medicine and Surgery, 24(12), 1238-1244. https://doi.org/10.1177/1098612X221074924
Miceli, D., Niessen, S.J.M., Rey, A.J.P., Zeugswetter, F.K., Pompili, G., Tavares, F., Molina, E., Leal, R., Espiñeira, I., Bota, D., Corsino, A., Fracassi, F. (2026). Hypersomatotropism without concurrent diabetes mellitus in cats: 28 cases (2014-2024). Journal of Veterinary Internal Medicine, 40(1). https://doi.org/10.1093/jvimsj/aalaf050
Niessen, S.J., Petrie, G., Gaudiano, F., Khalid, M., Smyth, J.B., Mahoney, P. & Church, D.B. (2007). Feline acromegaly: an underdiagnosed endocrinopathy. Journal of Veterinary Internal Medicine, 21(5), 899-905. https://doi.org/10.1892/08916640
Niessen, S.J. (2010). Feline Acromegaly an essential differential diagnosis for the difficult diabetic. Journal of Feline Medicine and Surgery, 12(1), 15-23. https://doi.org./10.1016/j-jfms.2009.12.003
Reusch, C.E., Kley, S., Nelson, R.W., Mol, J. & Zapf, J. (2006). Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus. Veterinary Record, 158(6), 195-200. https://doi.org/10.1136/vr.158.6.195
Rosca, M., Forcada, Y., Solcan, G., Igreja, D.B. & Niessen, S.J. (2014). Screening diabetic cats for hypersomatotropism: performance of an enzyme-linked immunosorbent assay for insulin-like growth factor 1. Journal of Feline Medicine and Sugery, 16(2), 82-8. https://doi.org/10.1177/1098612X13496246
Scudder, C., & Church, D. (2024). Feline comorbidities: hypersomatotropism-induced diabetes in cats. Journal of Feline Medicine and Sugery, 26(2), 1-10. https://doi.org/10.1177/1098612X241226690
Slingerland, L.I., Voorhout, G., Rijnberk, A., & Kooistra, H.S. (2008). Growth hormone excess and the effect of octreotide in cats with diabetes mellitus. Domestic Animal Endocrinology, 35(4), 352-61. https://doi.org./10.1016/j.domaniend.2008.07.004
Downloads
Publicado
Como Citar
Edição
Seção
Licença
- O conteúdo dos artigos é de responsabilidade exclusiva dos autores.
- É permitida a reprodução total ou parcial do conteúdo dos artigos, desde que citada a fonte.
- Artigos com plágio serão recusados, e o autor do plágio perderá o direito de publicar nesta revista.
- Os nomes e endereços informados nesta revista serão utilizados exclusivamente para os serviços prestados por esta publicação e não estão disponíveis para outros fins ou a terceiros.
- Depois de enviar os artigos, os autores cedem os direitos autorais de seus artigos ao BJAER. Se você se arrepender da submissão, o autor tem o direito de solicitar ao BJAER que não publique seu artigo. Porém, essa solicitação deve ocorrer até dois meses antes da divulgação do número que o artigo será publicado.
- O BJAER usa a licença Creative Commons CC BY. Informações sobre esta licença podem ser encontradas em: https://creativecommons.org/licenses/by/3.0/br/
Brazilian Journal of Animal and Environmental Research (BJAER) se reserva o direito de efetuar nos originais alterações de ordem normativa, ortográfica e gramatical, com vistas a manter o padrão culto da língua, respeitando, porém, o estilo dos autores. Os trabalhos finais não serão enviadas aos autores.
